Adverse Outcomes Associated With Inhaled Corticosteroid Use in Individuals With Chronic Obstructive Pulmonary Disease [Original Research]
Annals of Family Medicine
MARCH 24, 2025
PURPOSE We aimed to assess long-term inhaled corticosteroid (ICS) risks in chronic obstructive pulmonary disease (COPD) management. METHODS We extracted electronic health record data for individuals aged >45 years with COPD from a data repository. 2.68; P < 001) and inception (HR = 2.60; 95% CI, 2.56-2.64;
Let's personalize your content